Related Experiment Video
Updated: Aug 14, 2026

Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
[Effect of hyperbilirubinemia on biologic rhythms in healthy full-term neonates]
J Aldana Gómez1, M Revilla Ramos, J Andrés de Llano
1Departamento de Pediatría, Facultad de Medicina, Valladolid.
Objective:
The toxicity of bilirubin (BP) on the brain presents unknown aspects. Therefore, the treatment for neonatal hyperbilirubinemia is controversial. The aim of this study was to establish if moderate levels of BP produce toxicity in brain nuclei that regulate the biological rhythms (BR) of healthy full-term newborns.
Patients And Methods:
We studied 17 jaundiced (BP 12.8-18.1 mg/dl) and 36 non jaundiced newborns. Heart and respiratory rate, temperature and systolic blood pressure were recorded during 24 hours at 30 minute intervals. Cosinor analysis was used to calculate the incidence of BR. The Fisher exact test was carried out to compare both groups and the relative risks to determine the association between hyperbilirubinemia and the absence of BR.
Results:
Differences in the BR parameters did not reach statistical significance. Differences in heart rate 12-h BR (p = 0.071) and systolic blood pressure 8-h BR (p = 0.076) approached a statistical significance. The 95% confidence intervals of the relative risks were all close to 1 and the lower limits in respiratory rate (0.40) and systolic blood pressure (0.35) 24-h BR indicate a negative association.
Conclusions:
The aim was to verify the relationship between moderate neonatal hyperbilirubinemia and the decrease in the incidence of BR. The results do not show the sought after relationship and provide evidence against neurotoxicity from moderate levels of bilirubin. The limited evidence for developing long term mental alterations permits us to make an optimistic prognosis for full-term newborns with moderately elevated levels of bilirubin.
Related Concept Videos
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Jaundice

